Related by context. All words. (Click for frequent words.) 67 inversely associated 63 statistically significant correlation 61 statistically significant correlations 61 correlation 61 tHcy 60 causal relationship 60 dietary calcium intake 60 cardiovascular mortality 60 cardioprotective effects 59 epidemiologic studies 59 inverse relationship 59 statistically significant differences 59 multivariate adjustment 58 flavonoid intake 58 rs# [002] 58 cardioprotective effect 58 Epidemiologic studies 58 CVD mortality 58 utero exposure 58 nondiabetic patients 58 rs# [003] 57 familial aggregation 57 folate intake 57 familial clustering 57 subclinical hypothyroidism 57 colorectal neoplasia 57 NAT2 57 lowest tertile 57 GSTM1 57 rs# [004] 57 elevated CRP 57 dietary folate 57 univariate analysis 57 tertiles 57 elevated homocysteine 56 carotid atherosclerosis 56 gene polymorphism 56 lignan intake 56 thyrotropin levels 56 elevated ALT 56 highest tertile 56 hyperinsulinemia 56 myocardial uptake 56 nonfasting triglycerides 56 serum GGT 56 colorectal adenoma 56 Dr. Edward Giovannucci 56 plasma lipids 56 trans palmitoleate 56 SNP rs# [002] 56 nonfatal MI 55 advanced adenoma 55 eosinophil count 55 beta carotene supplementation 55 tertile 55 Multivariate analyzes 55 prognostic indicator 55 prognostic significance 55 fasting serum 55 acrylamide intake 55 phylloquinone 55 circulating IGF 55 Kivipelto 55 rCBF 55 Epidemiological studies 55 lowest quintile 55 transferrin saturation 54 highest quintile 54 DQB1 * 54 HbA 1c 54 Plasma concentrations 54 intact parathyroid hormone 54 subclinical atherosclerosis 54 diastolic BP 54 multivariable analysis 54 dietary acrylamide 54 cystatin C 54 nonsignificant 54 nicotine metabolite 54 biologically plausible 54 visceral adiposity 54 nondrinkers 54 fasting glucose levels 54 magnesium intake 54 monounsaturated fatty acids 54 coronary calcification 54 5 HTTLPR 54 Multivariate analysis 54 eicosapentaenoic acid 54 hormone receptor negative 54 serum vitamin D 54 confounder 54 folate deficiency 54 central adiposity 54 observational studies 54 adenoma 54 Calcium intake 54 sugar sweetened soft drinks 54 macrovascular disease 54 Subgroup analyzes 53 prognostic factor 53 dietary fiber intake 53 SHBG 53 polyp recurrence 53 rs# [001] 53 thiazide diuretics 53 ALB # 53 atherogenic dyslipidemia 53 statistically significant 53 tumor histology 53 serum uric acid 53 DRB1 * 53 serum estradiol 53 serum triglycerides 53 CLA supplementation 53 nondiabetic subjects 53 HER2 expression 53 abdominal adiposity 53 correlations 53 dietary intake 53 flow mediated dilation 53 causal link 53 serum concentrations 53 elevated uric acid 53 apolipoprotein B 53 cardiovascular morbidity 53 albumin excretion rate 53 coronary stenosis 53 causal pathway 53 kaempferol 53 serum calcium 53 body fatness 53 invasive lobular 53 estrone 53 Univariate analysis 53 TT genotype 53 esophageal squamous cell carcinoma 53 causal relation 53 fetuin 53 hydroxyvitamin D concentrations 53 hyperhomocysteinemia 53 fasting insulin 53 inverse correlation 53 protein excretion 53 probiotic supplementation 53 plasma leptin 53 pleiotropic effects 53 colorectal adenomas 53 distal colon cancer 53 plasma lipid 53 folates 53 monounsaturated fatty acid 53 GSTT1 53 SNP rs# [001] 53 confidence interval #.#-#.# 53 LDL particle 52 locoregional recurrence 52 metabolizing enzyme 52 pharmacokinetic interaction 52 eicosapentaenoic acid EPA 52 microbleeds 52 gallstone disease 52 neurological abnormalities 52 HOMA IR 52 interstitial lung abnormalities 52 residual confounding 52 urinary excretion 52 TIMP 52 highly heritable 52 CC genotype 52 fructosamine 52 sulcal 52 albuminuria 52 tHcy concentrations 52 gestational hypertension 52 mIU L 52 p = .# [002] 52 obese postmenopausal 52 DRD2 52 intima media thickness IMT 52 mL/min/#.# m 2 52 abnormal glucose tolerance 52 folate vitamin B 52 flavanol rich foods 52 homocysteine concentrations 52 MetS 52 prostate carcinogenesis 52 interindividual variability 52 inhibin B 52 VADT 52 nmol L 52 lipid abnormalities 52 FGFR2 52 NNRTI resistance 52 serum homocysteine 52 covariate 52 predisposing factor 52 hsCRP levels 52 drank caffeinated 52 Cotinine 52 adiponectin concentrations 52 APOE e4 52 ABCB1 52 serum creatinine levels 52 impaired glucose metabolism 52 glycated hemoglobin levels 52 subclinical hyperthyroidism 52 left ventricular dysfunction 52 nonfasting triglyceride levels 52 penetrance 52 HbA1C levels 52 impaired fasting glucose 52 SE alleles 52 serum selenium 52 nonfasting 52 HMG CoA reductase inhibitors 52 TEAEs 52 catechol O methyltransferase 52 aminotransferases 52 serum CRP 52 multivariate Cox 52 N telopeptide 52 plasma pharmacokinetics 52 % CI #.#-#.# [002] 52 CRP marker 52 SGPT 52 elevated hsCRP 52 colorectal cancer incidence 52 inherited predisposition 52 lipid concentrations 52 dietary patterns 52 impaired insulin secretion 52 Apolipoprotein E 52 metabolite concentrations 52 menaquinone 52 metabolic parameters 51 μmol L 51 promoter methylation 51 nonfatal stroke 51 elevated LDL cholesterol 51 logistic regression model 51 inflammatory markers 51 urinary oxalate 51 dietary antioxidants 51 mg BID dose 51 susceptibility locus 51 autonomic dysfunction 51 statistically significant reduction 51 umol L 51 thyrotropin 51 lipid profiles 51 coronary artery calcification 51 cardiorespiratory fitness 51 non fasting triglycerides 51 #mg/dL [001] 51 endothelial dysfunction 51 Pischon 51 Hazard Ratio HR 51 creatinine ratio 51 normotensive 51 plasma folate 51 total cholesterol triglycerides 51 E selectin 51 metabolic abnormalities 51 lipoprotein Lp 51 isoflavone intake 51 pg ml 51 NHANES III 51 mcg dL 51 biochemical abnormalities 51 nmol L. 51 SIBO 51 multivariable adjusted 51 epidemiological studies 51 Subgroup analysis 51 Cochrane reviewers 51 nonpregnant women 51 substudy 51 salivary cortisol 51 gene polymorphisms 51 cerebral infarction 51 VLDL cholesterol 51 adiposity 51 LDL HDL 51 heterozygotes 51 LV dysfunction 51 fructose sweetened beverages 51 borderline statistical significance 51 postprandial insulin 51 alanine aminotransferase 51 exhaled carbon monoxide 51 HGPIN 51 elevated serum creatinine 51 serum lipid levels 51 nondiabetic 51 perimenopausal women 51 hydroxyvitamin D levels 51 MGUS 51 Dietary intake 51 shorter telomere length 51 BRCA1 mutations 51 baseline serum creatinine 51 dietary intakes 51 carotid plaques 51 elevated LDH 51 SLC#A# [002] 51 lobular involution 51 multivariate analysis 51 antioxidant supplementation 51 selenium intake 51 Susanna Larsson 51 serum PSA 51 use disorders AUDs 51 serum retinol 51 immunoreactivity 51 prenatal exposures 51 nmol l 51 macrophage infiltration 51 caffeinated coffee 51 sugar sweetened cola 51 Winkelmayer 51 triglyceride concentrations 51 pre menopausal 51 pCR 51 Multiethnic Study 51 correlated inversely 51 LDL cholesterol concentrations 51 serum parathyroid hormone 51 phthalate metabolites 51 polyunsaturated fatty acid 51 vasodilatation 51 alanine aminotransferase ALT 51 vitamin K1 51 nonobese 51 prepubertal 50 CYP#D# inhibitor 50 arachidonic acid AA 50 PUFA intake 50 nmol 50 macronutrient intake 50 Djousse 50 multivariate analyzes 50 urinary albumin 50 prospective cohort 50 serum cholesterol 50 meta analysis 50 Elevated serum 50 parous women 50 plasma selenium 50 macroalbuminuria 50 cardio protective 50 #ng/ml 50 circulating estrogens 50 carotid stenosis 50 differentially expressed 50 authors conclude 50 oesophageal adenocarcinoma 50 serum leptin 50 serum folate 50 endometrial hyperplasia 50 BMI z 50 colorectal carcinoma 50 plasma homocysteine 50 cardiomegaly 50 carotid bruit 50 strongest predictor 50 Endothelial dysfunction 50 histologic subtype 50 intima media thickness 50 neurodevelopmental outcome 50 vegetable intake 50 obstructive coronary artery 50 ß carotene 50 glycosylated hemoglobin 50 recurrent venous thromboembolism 50 hormone receptor status 50 Leitzmann 50 antidepressant efficacy 50 atypical hyperplasia 50 HNSCC 50 TIMP 1 50 inverse relation 50 fatty acid intake 50 apolipoproteins 50 mmol l 50 urinary concentrations 50 microvascular complications 50 XIENCE V demonstrated 50 C reactive protein 50 albumin excretion 50 HDL cholesterol triglycerides 50 dysregulation 50 observational study 50 FDG uptake 50 androgen suppression 50 8 OHdG 50 selenium supplementation 50 Observational studies 50 univariate 50 serum PTH 50 Ascherio 50 serum lipids 50 #.#mg/dL 50 GBA mutations 50 confidence interval CI 50 elevated creatinine 50 coronary artery atherosclerosis 50 arterial occlusion 50 advanced adenomas 50 univariate analyzes 50 atherogenic 50 mRNA expression 50 elevated cortisol 50 premenopausal breast cancer 50 desvenlafaxine succinate 50 comorbid illnesses 50 estrogen metabolism 50 glucose insulin 50 androgen deficiency 50 biochemical recurrence 50 prevalences 50 telomere lengths 50 coronary heart 50 Stent thrombosis 50 dietary glycemic index 50 HMGA1 50 ovarian carcinoma 50 menarche 50 elevated triglyceride levels 50 serum BDNF 50 dehydroepiandrosterone sulfate 50 variant alleles 50 μg g 50 lifetime abstainers 50 GSTM1 gene 50 flavanol rich cocoa 50 Pharmacokinetic 50 MERLIN TIMI 50 ECG abnormalities 50 alexithymia 50 B vitamin supplementation 50 Lp PLA2 50 MTHFR 50 KIF6 carriers 50 untreated hypothyroidism 50 APOE genotype 50 serum cotinine levels 50 genetic polymorphisms 50 subgroup analyzes 50 extrapyramidal symptoms 50 Dietary Modification Trial 50 dose dependently 50 intraobserver 50 QTc prolongation 50 plasma triglycerides 50 AML MDS 50 prospectively defined 50 adiponectin levels 50 inhibitory effects 50 Edward Giovannucci 50 apnea hypopnea index 50 serum urate levels 50 Boston DbTechNo Results 50 diastolic blood pressures 50 carotid IMT 50 carotid plaque 50 BMI waist circumference 50 Previous observational studies 50 CYP #A# 50 Fasting blood glucose 50 lobular carcinoma 50 TCF#L# 50 echocardiographic parameters 50 adiponectin 50 prenatal exposure 50 laboratory abnormalities 50 hypoglycemic episodes 50 calcium excretion 50 #q# deletion 50 C. pneumoniae 50 serum TSH 49 gamma tocopherol 49 potentially modifiable 49 paraoxonase 49 troponin T 49 systolic dysfunction 49 macrovascular 49 density lipoprotein HDL cholesterol 49 chromosome #q# [001] 49 Prehypertension 49 linoleic acid LA 49 alcohol dehydrogenase ADH 49 antiphospholipid antibodies 49 osteopenic 49 calcium supplementation 49 Hilakivi Clarke 49 Logistic regression analysis 49 urinary calcium 49 CHD mortality 49 left ventricular hypertrophy 49 elevated fasting glucose 49 glycosylated hemoglobin HbA1c 49 nutrient intakes 49 silent myocardial ischemia 49 serum ALT 49 polymorphisms 49 PSA kinetics 49 acylated ghrelin 49 hyperplastic polyps 49 homozygosity 49 periprocedural MI 49 phytoestrogen 49 systolic BP 49 sitosterol 49 monozygotic twins 49 calcium intake 49 SHBG levels 49 shorter telomeres 49 serum phosphate 49 DHA supplementation 49 cortical thinning 49 cholesterol LDL C 49 orofacial clefts 49 Hcy 49 dysuria 49 multi factorial disease 49 prostate cancer CaP 49 dapagliflozin plus 49 #q# [001] 49 dysbindin 49 metabolic dysfunction 49 G allele 49 left ventricular diastolic 49 alpha tocopherol 49 clinically meaningful differences 49 lipid levels 49 PLX STROKE targeting 49 inflammatory biomarkers 49 vitamin D inadequacy 49 phytoestrogen intake 49 lactate dehydrogenase 49 Kaplan Meier curve 49 acetabular dysplasia 49 Lp lipoprotein 49 comorbidity 49 WNK1 49 phyto oestrogens 49 corrected QT interval 49 PM#.# exposure 49 latent celiac disease 49 NAFLD 49 mmol liter 49 dietary folate intake 49 phytoestrogens 49 susceptibility loci 49 triacylglycerol concentrations 49 lymph node involvement 49 hyperalgesia 49 palmitic acid 49 polyunsaturated fat 49 AST ALT 49 saturated fatty acid 49 upregulates 49 resistin 49 systolic blood pressure 49 glomerular 49 Singh Manoux 49 breast cancer subtypes 49 dysglycemia 49 socioeconomic gradient 49 lipid lowering medications 49 density lipoprotein cholesterol 49 salivary cotinine 49 correlational 49 probable stent thrombosis 49 % CI #.#-#.# [006] 49 postmenopausal breast cancer 49 cotinine levels 49 scintigraphic 49 Hypoglycaemia 49 triacylglycerol 49 overt hypothyroidism 49 Clinical Endocrinology & 49 insulin resistance precursor 49 subclinical cardiovascular disease 49 habitual snoring 49 #OHD levels 49 morphometric vertebral fractures 49 HPA axis 49 beta carotene supplements 49 aminotransferase ALT 49 folate concentrations 49 abdominal obesity 49 baseline FEV 49 ExTRACT TIMI 49 abnormal glucose metabolism 49 biological plausibility 49 neurodevelopmental outcomes 49 hypertriglyceridemia 49 adrenocortical 49 serum IGF 49 hs CRP 49 Meta Analysis 49 Baseline characteristics 49 hypertension hypercholesterolemia 49 μg L 49 improves insulin sensitivity 49 DHEAS 49 surrogate marker 49 arterial thickening 49 contralateral breast cancer 49 GABRA2 49 PON1 49 causal pathways 49 colorectal neoplasms 49 serum lipid 49 Insulin sensitivity 49 receptor inhibitor 49 RBC folate 49 hepatic lipase 49 parkinsonism 49 ConclusionThis 49 VLBW 49 Hashibe 49 Helicobacter pylori infection 49 subclinical 49 depressive symptomatology 49 elevated triglycerides 49 antitumor effect 49 RE LY trial 49 delayed gastric emptying 49 anovulatory infertility 49 adenomatous 49 Chronic pancreatitis 49 APOE ε4 49 blood glucose concentrations 49 Boffetta 49 cardiac dysfunction 49 antibody titer 49 carotid artery intima media 49 striatal 49 interobserver reliability 49 VCAM 1 49 interobserver agreement 49 pressure natriuresis 49 nonseminoma 49 PLCO trial 49 flavonol rich 49 TMPRSS2 ERG fusion 49 noncarriers 49 endometrial thickness 49 confounders 49 BRCA2 mutation carriers 49 proximal colon 49 menstrual irregularity 49 Angiotensin converting enzyme 49 definite stent thrombosis 49 GFT# 49 obesity sedentary lifestyle 49 fasting triglycerides 48 detrusor 48 riociguat 48 metabolizing enzymes 48 Dietary fat 48 exposed prenatally 48 inflammatory rheumatic 48 psychosocial variables 48 modifiable lifestyle 48 coinfection 48 ipsilateral 48 IPAH 48 nonsignificant difference 48 perinatal outcomes 48 colorectal polyp 48 abdominal circumference 48 ATACAND 48 myometrium 48 ischemic cardiovascular 48 HLA DRB1 SE 48 heterozygous familial 48 etiologic 48 serum folate concentrations 48 Concord grape juice 48 depressive symptoms 48 multivariable Cox 48 Tasigna prolongs 48 TCF#L# gene 48 comorbid depression 48 carotid intima media 48 MMSE score 48 myeloperoxidase 48 HDL C 48 gyri 48 adenocarcinoma histology 48 azoospermia 48 CHD coronary 48 HDL2 48 HepG2 cells 48 biologic plausibility 48 hematological parameters 48 hip BMD 48 LDL cholesterol HDL cholesterol 48 symptomatic VTE 48 reach statistical significance 48 achieved statistical significance 48 Genetic variation 48 infarcts 48 metabolic disturbances 48 heritability 48 CIN2 + 48 ventricular hypertrophy 48 genetic determinants 48 XZK 48 aminotransferase levels 48 renal dysfunction 48 Soy isoflavones 48 nonhereditary 48 aspartate aminotransferase 48 enterovirus infection 48 maintaining cardiorespiratory fitness 48 pharmacokinetics PK 48 venous thrombosis 48 estrogenic effects 48 HER2 positivity 48 congenital malformations 48 diastolic hypertension 48 plasma cortisol 48 basal cell nevus syndrome 48 randomized controlled trials 48 Genetic predisposition 48 cardio respiratory fitness 48 hyperglycaemia 48 nanomoles per 48 kcal d 48 perfusion defects 48 H. pylori eradication 48 inorganic nitrate 48 MMSE scores 48 paraneoplastic 48 hypercalciuria 48 intracerebral hemorrhage 48 Kaplan Meier analysis 48 meta regression 48 interobserver 48 birthweight 48 metabolized differently 48 Lp PLA 2 48 artificially sweetened soft drinks 48 #OHD 48 XP# Transported Prodrug 48 DHEA supplementation 48 neuropsychiatric symptoms 48 PITX2 48 primary aldosteronism 48 Plain radiographs 48 prostate cancer PCa 48 CagA 48 calcium intakes 48 stone formers 48 chromosomal alterations 48 sperm morphology 48 Homocysteine 48 postoperative mortality 48 leukocyte telomere length 48 induced oxidative stress 48 K ras mutations 48 β carotene 48 severe periodontitis 48 spontaneous preterm delivery 48 glycemia 48 serum cortisol 48 hemodilution 48 glycated hemoglobin HbA1c 48 locomotor activity 48 CARDIA study 48 atherosclerotic progression 48 modifiable risk 48 wholegrain cereals 48 intracranial atherosclerosis 48 confounding factors 48 abstinent alcoholics 48 dose proportionality 48 Dietary intakes 48 microdeletion 48 gene APOE 48 onset diabetes mellitus 48 underactive thyroid gland 48 Conclusions 48 clinically meaningful reductions 48 IGFBP 48 genetic variants associated 48 hyperintensity 48 paricalcitol 48 hepatic fibrosis 48 waist circumference WC 48 white matter hyperintensities 48 metformin monotherapy 48 vitro studies 48 linear pharmacokinetics 48 CP CPPS 48 chromosomal instability 48 #.#mmHg 48 neuroprotective effects 48 folate supplementation 48 angiographically 48 leptin deficient mice 48 statistical correlations 48 pharmacokinetic characteristics 48 aminotransferase 48 nondepressed 48 ovarian hormones 48 haemorrhagic stroke 48 vertebral fracture 48 CHD 48 myocardial infarctions 48 arterial stiffness 48 serum biomarkers 48 HDL cholesterol concentrations 48 abnormal lipid 48 headache nasopharyngitis 48 diabetes mellitus hypertension 48 androgen depletion 48 hypercholesterolaemia 48 liver metastasis 48 Wactawski Wende 48 subanalysis 48 dense LDL 48 nephrolithiasis 48 clinically insignificant 48 preeclamptic 48 UGT#A# * 48 CR nPR 48 hypoperfusion 48 pharmacokinetic interactions 48 LUTS 48 neurocognitive deficits 48 apolipoprotein E APOE 48 vitamin D intakes 48 Nutrition EPIC 48 polyunsaturated fatty acids PUFAs 48 mm Hg diastolic 48 CR CRu 48 liver transplant recipients 48 MMP# 48 Hyperlipidemia 48 PAEE 48 male circumcision reduces 48 chromium supplementation 48 LPS induced 48 prolactin levels 48 nodal metastases 48 NNT = 48 B7 H3 48 visceral adipose tissue 48 alkaline phosphatase ALP 48 PRADAXA #mg 48 preterm delivery 48 leiomyomas 48 Serum concentrations 48 Atkins dieters cardiovascular 48 aortic atherosclerosis 48 FGFR2 gene 48 thromboembolic complications 48 EGFR expression 48 gross hematuria 48 socioeconomic deprivation 48 #q#.# deletion syndrome 48 mmHg diastolic 48 intracranial hemorrhage ICH 48 serum glucose 48 circadian clock genes 48 neuroimaging studies 48 Histologic 48 psychiatric comorbidity 48 APOC3 48 atherothrombotic disease 48 hippocampal volume 48 premenopausal women 48 logistic regression analyzes 48 Cardiorespiratory fitness 48 lispro 48 chromosome #q# [002] 48 nonischemic 48 creatine kinase 48 ng ml 47 μg d 47 neuritic 47 dietary DHA 47 oral glucose tolerance 47 periodontitis 47 nmol liter 47 LV ejection fraction 47 GSTP1 47 inecalcitol 47 bivariate 47 oxycodone CR 47 peak VO2 47 cryptogenic 47 testicular germ cell 47 statistically significant p = 47 aspartate aminotransferase AST 47 hypothalamic 47 pre eclamptic 47 mineral density 47 atopic asthma 47 renal artery stenosis 47 #:#-# [029] 47 myocardial infarction MI 47 bronchoalveolar 47 mucinous 47 RBP4 47 inorganic phosphates 47 Thiazolidinediones 47 serum markers 47 creatine supplementation 47 genetic loci 47 Fasting glucose 47 amenorrhea 47 arterial thromboembolic events 47 polyphenol rich 47 DLTs 47 multivariate logistic regression 47 plasma glucose 47 atopy 47 elevated prolactin 47 lycopene intake 47 pharmacokinetic equivalence 47 Aging USDA HNRCA 47 oxidized phospholipids 47 femoral neck bone 47 β = 47 drank colas 47 N acetylaspartate 47 distensibility 47 hemodynamically significant 47 chromosomal regions 47 insulin sensitizing drug 47 elevated bilirubin 47 pretest probability 47 platelet activation 47 antioxidant intake 47 endothelium dependent 47 retinol binding protein 47 statistically significant efficacy 47 SRBD 47 psychiatric comorbidities 47 spirometric 47 cTnI 47 dietary fructose 47 Levels Linked 47 pressor response 47 desire disorder HSDD 47 hyperlipidaemia 47 PON1 gene 47 thyroid hormone levels 47 airway hyper responsiveness 47 microalbuminuria 47 CETP inhibition 47 statistically nonsignificant 47 periodontal infection 47 hesperidin 47 paclitaxel eluting stents 47 mammographic density 47 malondialdehyde 47 % Confidence Interval 47 mGluR5 NAM 47 CANCER peer reviewed 47 LDL HDL ratio 47 symptomatic intracerebral hemorrhage 47 APOA5 47 chromosome #p# [002] 47 thromboembolism 47 Cystatin C 47 affective disorders 47 Dariush Mozaffarian 47 thyroid dysfunction 47 #mg/day [001] 47 IDH mutations 47 postprandial glycemia 47 equol producers 47 F FDG PET 47 systolic blood pressures 47 subclinical inflammation 47 allergic sensitization 47 eplerenone 47 orthologs 47 #.#mmol L [002] 47 Endothelial function 47 Subclinical 47 positively correlated 47 hereditary predisposition 47 sarcosine 47 Multi Ethnic Study 47 aortic stiffness 47 preoperative PSA 47 randomized trials 47 causal 47 diabetes dyslipidemia 47 hemoglobin A1c HbA1c